APRT Human shRNA Plasmid Kit (Locus ID 353)
CAT#: TG320095
APRT - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | APRT Human shRNA Plasmid Kit (Locus ID 353) |
Locus ID | 353 |
UniProt ID | P07741 |
Synonyms | AMP; APRTD |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | APRT - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 353). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_000485, NM_001030018, NM_000485.1, NM_000485.2, NM_001030018.1, BC107151, BC106894, BC106895, BM423481, BM550173, NM_001030018.2, NM_000485.3 |
Summary | Adenine phosphoribosyltransferase belongs to the purine/pyrimidine phosphoribosyltransferase family. A conserved feature of this gene is the distribution of CpG dinucleotides. This enzyme catalyzes the formation of AMP and inorganic pyrophosphate from adenine and 5-phosphoribosyl-1-pyrophosphate (PRPP). It also produces adenine as a by-product of the polyamine biosynthesis pathway. A homozygous deficiency in this enzyme causes 2,8-dihydroxyadenine urolithiasis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
Activation of AMP-Activated Protein Kinase by Adenine Alleviates TNF-Alpha-Induced Inflammation in Human Umbilical Vein Endothelial Cells
,Cheng, YF;Young, GH;Lin, JT;Jang, HH;Chen, CC;Nong, JY;Chen, PK;Kuo, CY;Kao, SH;Liang, YJ;Chen, HM;,
PLoS ONE
,PubMed ID 26544976
[APRT]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...